Proteomic analysis identifies alterations in cellular morphology and cell death pathways in mouse brain after chronic corticosterone treatment

Brain Research

Volumn 1102, Issue 1, 2006, Pages 12-26

  Skynner, Heather A ^a   Amos, Doran P ^a   Murray, Fraser ^a   Salim, Kamran ^a   Knowles, Michael R ^a   Munoz Sanjuan, Ignacio ^a   Camargo, Luis M ^a   Bonnert, Timothy P ^a   Guest, Paul C ^a  

^a NEUROSCIENCE RESEARCH CENTRE   (United Kingdom)

Author keywords

Biological variation analysis; Differential in gel analysis; Matrix assisted laser desorption ionization time of flight mass spectrometry; Proteomics; Two dimensional gel electrophoresis

Indexed keywords

BIOLOGICAL MARKER; CORTICOSTEROID; GLUTAMIC ACID; NITROGEN; PHENYLALANINE; PROTEIN;

AMINO ACID METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN FUNCTION; BRAIN METABOLISM; BRAIN NERVE CELL; BRAIN REGION; CELL STRUCTURE; COMPARATIVE STUDY; CONTROLLED STUDY; FUNCTIONAL PROTEOMICS; GLUCONEOGENESIS; GLYCOLYSIS; HIPPOCAMPUS; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS SYSTEM; LONG TERM EXPOSURE; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOUSE; NERVE CELL NECROSIS; NITROGEN METABOLISM; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BLOTTING, WESTERN; BRAIN; BRAIN MAPPING; CELL DEATH; CORTICOSTERONE; DRUG ADMINISTRATION SCHEDULE; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GENE EXPRESSION; MALE; MICE; MODELS, BIOLOGICAL; NEURAL PATHWAYS; PROTEOMICS;

EID: 33746214623     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2006.04.112     Document Type: Article

References (35)

1. Arana G.W., Baldessarini R.J., and Ornsteen M. The dexamethasone suppression test for diagnosis and prognosis in psychiatry. Arch. Gen. Psychiatry 42 (1985) 1193-1204
2. Arimura N., Menager C., Fukata Y., and Kaibuchi K.J. Role of CRMP-2 in neuronal polarity. Neurobiology 58 (2004) 34-47
3. Bloom B.S. Prevalence and economic effects of depression. Manag. Care 13 6 Suppl (2004) 9-16
4. Blum D., Hemming F.J., Galas M.C., Torch S., Cuvelier L., Schiffmann S.N., and Sadoul R. Increased Alix (apoptosis-linked gene-2 interacting protein X) immunoreactivity in the degenerating striatum of rats chronically treated by 3-nitropropionic acid. Neurosci. Lett. 368 (2004) 309-313
5. Bourdeau I., Bard C., Noel B., Leclerc I., Cordeau M.P., Belair M., Lesage J., Lafontaine L., and Lacroix A.J. A loss of brain volume in endogenous Cushing's syndrome and its reversibility after correction of hypercortisolism. J. Clin. Endocrinol. Metab. 87 (2002) 1949-1954
6. Bremner J.D., Narayan M., Anderson E.R., Staib L.H., Miller H.L., and Charney D.S. Hippocampal volume reduction in major depression. Am. J. Psychiatry 157 (2000) 115-118
7. Czéh B., Welt T., Fischer A.K., Erhardt A., Schmitt W., Müller M.B., Toschi N., Fuchs E., and Keck M.E. Chronic psychosocial stress and concomitant repetitive transcranial magnetic stimulation: effects on stress hormone levels and adult hippocampal neurogenesis. Biol. Psychiatry 52 (2002) 1057-1065
8. Datson N.A., van der Perk J., de Kloet E.R., and Vreugdenhil E. Identification of corticosteroid-responsive genes in rat hippocampus using serial analysis of gene expression. Eur. J. Neurosci. 14 (2001) 675-689
9. Fukata Y., Kimura T., and Kaibuchi K. Axon specification in hippocampal neurons. Neurosci. Res. 43 (2002) 305-315
10. Guest P.C., Salim K., Skynner H.A., George S.E., Bresnick J.N., and McAllister G. Identification and characterization of a truncated variant of the 5-hydroxytryptamine(2A) receptor produced by alternative splicing. Brain Res. 876 (2000) 238-244
11. Guest P.C., Knowles M.R., Molon-Noblot S., Salim K., Smith D., Murray F., Laroque P., Hunt S.P., De Felipe C., Rupniak N.M., and McAllister G. Mechanisms of action of the antidepressants fluoxetine and the substance P antagonist l-000760735 are associated with altered neurofilaments and synaptic remodeling. Brain Res. 1002 (2004) 1-10
12. Gronholm M., Vossebein L., Carlson C.R., Kuja-Panula J., Teesalu T., Alfthan K., Vaheri A., Rauvala H., Herberg F.W., Tasken K., and Carpen O. Merlin links to the cAMP neuronal signaling pathway by anchoring the RIbeta subunit of protein kinase A. J. Biol. Chem. 278 (2003) 41167-41172
13. Hemming F.J., Fraboulet S., Blot B., and Sadoul R. Early increase of apoptosis-linked gene-2 interacting protein X in areas of kainate-induced neurodegeneration. Neuroscience 123 (2004) 887-895
14. Inagaki N., Chihara K., Arimura N., Menager C., Kawano Y., Matsuo N., Nishimura T., Amano M., and Kaibuchi K. CRMP-2 induces axons in cultured hippocampal neurons. Nat. Neurosci. 4 (2001) 781-782
15. Karten Y.J., Olariu A., and Cameron H.A. Stress in early life inhibits neurogenesis in adulthood. Trends Neurosci. 28 (2005) 171-172
16. Khawaja X., Xu J., Liang J.J., and Barrett J.E. Proteomic analysis of protein changes developing in rat hippocampus after chronic antidepressant treatment: implications for depressive disorders and future therapies. J. Neurosci. Res. 75 (2004) 451-460
17. Kino T., and Chrousos G.P. Glucocorticoid and mineralocorticoid receptors and associated diseases. Essays Biochem. 40 (2004) 137-155
18. Knowles M.R., Cervino S., Skynner H.A., Hunt S.P., de Felipe C., Salim K., Meneses-Lorente G., McAllister G., and Guest P.C. Multiplex proteomic analysis by two-dimensional differential in-gel electrophoresis. Proteomics 3 (2003) 1162-1171
19. Lee A.L., Ogle W.O., and Sapolsky R.M. Stress and depression: possible links to neuron death in the hippocampus. Bipolar Disord. 4 (2002) 117-128
20. Malberg J.E., Eisch A.J., Nestler E.J., and Duman R.S. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J. Neurosci. 20 (2000) 9104-9110
21. Martinez-Hernandez A., Bell K.P., and Norenberg M.D. Glutamine synthetase: glial localization in brain. Science 195 (1977) 1356-1358
22. McIntosh L.J., Cortopassi K.M., and Sapolsky R.M. Glucocorticoids may alter antioxidant enzyme capacity in the brain: baseline studies. Brain Res. 791 (1998) 215-222
23. Molloy M.P., Herbert B.R., Walsh B.J., Tyler M.I., Traini M., Sanchez J.C., Hochstrasser D.F., Williams K.L., and Gooley A.A. Extraction of membrane proteins by differential solubilization for separation using two-dimensional gel electrophoresis. Electrophoresis 19 (1998) 837-844
24. Paul I.A., and Skolnick P. Glutamate and depression: clinical and preclinical studies. Ann. N. Y. Acad. Sci. 1003 (2003) 250-272
25. Raponi M., Belly R.T., Karp J.E., Lancet J.E., Atkins D., and Wang Y. Microarray analysis reveals genetic pathways modulated by tipifarnib in acute myeloid leukaemia. BMC Cancer 4 (2004) 56
26. Sala M., Perez J., Soloff P., Ucelli S., di Nemi E., Caverzasi J., Soares C., and Brambila P. Stress and hippocampal abnormalities in psychiatric disorders. Eur. Neuropsychopharmacol. 14 (2004) 393-405
27. Sandstrom N.J., and Hart S.R. Isolation stress during the third postnatal week alters radial arm maze performance and corticosterone levels in adulthood. Behav. Brain Res. 156 (2005) 289-296
28. Sapolsky R.M. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch. Gen. Psychiatry 57 (2000) 925-935
29. Sheline Y.I., Wang P.W., Gado M.H., Csernansky J.G., and Vannier M.W. Hippocampal atrophy in recurrent major depression. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 3908-3913
30. Sheline Y.I., Sanghavi M., Mintun M.A., and Gado M.H.J. Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression. Neuroscience 19 (1999) 5034-5043
31. Siripurapu V., Meth J., Kobayashi N., and Hamaguchi M. DBC2 significantly influences cell-cycle, apoptosis, cytoskeleton and membrane-trafficking pathways. J. Mol. Biol. 346 (2005) 83-89
32. Unlu M., Morgan M.E., and Minden J.S. Difference gel electrophoresis: a single gel method for detecting changes in protein extracts. Electrophoresis 18 (1997) 2071-2077
33. Whiteford H.A., Peabody C.A., Csernansky J.G., Warner M.D., and Berger P.A.J. Elevated baseline and postdexamethasone cortisol levels. A reflection of severity or endogeneity?. Affect. Disord. 12 (1987) 199-202
34. Wilm M., Shevchenko A., and Houthaeve T. Femtomole sequencing of proteins from polyacrylamide gels by nano-electrospray mass spectrometry. Nature 379 (1996) 466-469
35. Wong M.L., O'Kirwan F., Hannestad J.P., Irizarry K.J., Elashoff D., and Licinio J. St John's wort and imipramine-induced gene expression profiles identify cellular functions relevant to antidepressant action and novel pharmacogenetic candidates for the phenotype of antidepressant treatment response. Mol. Psychiatry 9 (2004) 237-251